DMPK and neoplasm: Additional screening revealed that compound could target Aurora B, Aurora C, NEK10, polo-like kinase (PLK2, PLK3), dystrophia myotonica protein kinases-1 (DMPK) and CAMK1, and the authors then speculated that GeGe-3 alters angiogenesis by targeting DMPK in tumor endothelial cells and pericytes.